Ryoko Yoshikawa

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity

Shigeyuki Chaki, Ryoko Yoshikawa, Shiho Hirota et al. · Neuropharmacology · 2003 · 250 citations

Antidepressant-like Activity, Psychoactive Drug, Psychiatry +11

Design, synthesis and structure–affinity relationships of aryloxyanilide derivatives as novel peripheral benzodiazepine receptor ligands

Taketoshi Okubo, Ryoko Yoshikawa, Shigeyuki Chaki et al. · Bioorganic & Medicinal Chemistry · 2003 · 156 citations

Molecular Pharmacology, Pharmaceutical Chemistry, Derivatives +8

Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor Agonists

Atsuro Nakazato, Toshihito Kumagai, Kazunari Sakagami et al. · Journal of Medicinal Chemistry · 2000 · 114 citations · Full text

Combinatorial Chemistry, Medicinal Chemistry, Pharmacological Characterization +15

Long noncoding RNA, CCDC26, controls myeloid leukemia cell growth through regulation of KIT expression

Tetsuo Hirano, Ryoko Yoshikawa, Hironori Harada et al. · Molecular Cancer · 2015 · 107 citations · Full text

Neuropharmacological profile of peripheral benzodiazepine receptor agonists, DAA1097 and DAA1106

Shigeru Okuyama, Shigeyuki Chaki, Ryoko Yoshikawa et al. · Life Sciences · 1999 · 90 citations

Molecular Pharmacology, Neuropharmacological Profile, Neurophysiology +10